T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
STRATTEC Security
STRT
$338M
| $10.7M | ﹤0.01% |
246,082
-4,300
| -2% | -$188K |
|
|
XYZ
1327
Block Inc
XYZ
$49.9B
| $10.7M | ﹤0.01% |
308,440
+257,548
| +506% | +$9.43M |
|
1328
Enbridge
ENB
$112B
| $10.6M | ﹤0.01% |
270,874
-3,213,990
| -92% | -$124M |
|
|
PBCT
1329
DELISTED
People's United Financial Inc
PBCT
| $10.5M | ﹤0.01% |
561,129
+1,933
| +0.3% | +$35.8K |
|
1330
Assurant
AIZ
$13.9B
| $10.4M | ﹤0.01% |
103,387
-5,200
| -5% | -$514K |
|
1331
Rigel Pharmaceuticals
RIGL
$762M
| $10.4M | ﹤0.01% |
268,395
-9,720
| -3% | -$370K |
|
1332
Globant
GLOB
$1.77B
| $10.4M | ﹤0.01% |
223,409
+36,849
| +20% | +$1.48M |
|
1333
RPC Inc
RES
$1.4B
| $10.3M | ﹤0.01% |
+404,423
| New | +$9.74M |
|
|
PACW
1334
DELISTED
PacWest Bancorp
PACW
| $10.3M | ﹤0.01% |
204,007
+168,730
| +478% | +$8.05M |
|
1335
H&R Block
HRB
$6.76B
| $10.2M | ﹤0.01% |
390,572
+6,000
| +2% | +$156K |
|
1336
lululemon athletica
LULU
$13.6B
| $10.2M | ﹤0.01% |
129,822
+4,950
| +4% | +$330K |
|
|
AKAO
1337
DELISTED
Achaogen Inc
AKAO
| $10.2M | ﹤0.01% |
947,056
+8,180
| +0.9% | +$103K |
|
|
BHVN
1338
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $10.1M | ﹤0.01% |
375,048
+1,100
| +0.3% | +$30.3K |
|
1339
Minerva Neurosciences
NERV
$187M
| $10.1M | ﹤0.01% |
208,514
+175
| +0.1% | +$8.68K |
|
|
OSG
1340
DELISTED
Overseas Shipholding Group Inc.
OSG
| $10.1M | ﹤0.01% |
3,682,645
-536,992
| -13% | -$1.4M |
|
|
FL
1341
DELISTED
Foot Locker
FL
| $10M | ﹤0.01% |
213,826
-28,750
| -12% | -$1.07M |
|
|
ESL
1342
DELISTED
Esterline Technologies
ESL
| $9.95M | ﹤0.01% |
133,212
-26,664
| -17% | -$2.19M |
|
1343
Signet Jewelers
SIG
$3.59B
| $9.89M | ﹤0.01% |
174,890
-6,150
| -3% | -$376K |
|
|
GRMN
1344
Garmin
GRMN
$59.8B
| $9.87M | ﹤0.01% |
165,679
-30,200
| -15% | -$1.77M |
|
1345
REX American Resources
REX
$1.44B
| $9.79M | ﹤0.01% |
709,704
-13,698
| -2% | -$201K |
|
|
JWN
1346
DELISTED
Nordstrom
JWN
| $9.53M | ﹤0.01% |
201,038
+10,170
| +5% | +$438K |
|
1347
CALL
Genuine Parts
GPC
$18.5B
| $9.5M | ﹤0.01% |
100,000
| – | – |
|
|
WBC
1348
DELISTED
WABCO HOLDINGS INC.
WBC
| $9.4M | ﹤0.01% |
65,519
-1,416,862
| -96% | -$208M |
|
|
NETS
1349
DELISTED
Netshoes (Cayman) Limited
NETS
| $9.33M | ﹤0.01% |
1,180,718
+543,536
| +85% | +$4.96M |
|
1350
ON Semiconductor
ON
$31.8B
| $9.28M | ﹤0.01% |
443,299
-6,401
| -1% | -$131K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.